Announcements Trials
Browse Landscape

Phase

Phase 2 15Phase 1 12Phase NA 11Phase 3 3Phase 4 2Phase 2/3 2Phase 1/2 2Phase EARLY_PHASE1 1

Status

Completed 24Unknown 9Terminated 5Recruiting 4Not yet recruiting 2Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 30Breast 23Gynecologic 11Thoracic 10Lymphoid 10Plasma cell 7Other hematologic neoplasm 7Genitourinary 7Classical hematology 7Dermatologic 5Other 4Head & Neck 4Endocrine 3Myeloid 2CNS 2Sarcoma 1Other solid neoplasm 1NET 1

Conditions

Polycythemia Vera 1Myeloproliferative Disorders 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

flumatinib 1Phlebotomy 1Imatinib Mesylate 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Not yet recruiting × Myeloid × Clear all
NCT06290765 2025-07-31

PV

PharmaEssentia

Phase 4 Not yet recruiting
70 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera

NCT05367765 2022-05-10

A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

Jiangsu Hansoh Pharmaceutical Co., Ltd.

Phase 4 Not yet recruiting
2,400 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡